RGNX
#2751
REGENXBIO Inc. - Common Stock
12.7 5 USD
-0.09%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-8.60%
Monthly Change
+100.47%
6 month change
-17.58%
Year Change
-5.06%
Previous Close
13.9 5
Open
12.7 5
Low
12.7 5
High
12.7 5
Volume
119
Financials
- Market Capitalization 659.14 M
- Employee 371
- Founded 2008
- CEO N/A
- Website www.regenxbio.com
- Headquarter Maryland, United States
- FIGI BBG007Z9V591
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.83
Price to sales ratio
4.36
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2744 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 1.93 USD | -3.50% | -8.10% | +2.66% | +51.97% | 666.15 M USD | ||
| 2750 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 34.34 USD | -0.09% | -2.75% | +17.20% | +100.23% | 647.97 M USD | ||
| 2757 |  PRME Prime Medicine, Inc. - Common Stock | 3.52 USD | -6.88% | -13.30% | +24.82% | -18.14% | 635.77 M USD | ||
| 2767 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 6.10 USD | -0.16% | -3.94% | +10.51% | +131.06% | 626.22 M USD |
Frequently asked questions about REGENXBIO Inc. - Common Stock
What is the REGENXBIO Inc. - Common Stock stock price today?
The current price of REGENXBIO Inc. - Common Stock (RGNX) is 12.75. Over the past 24 hours, the stock has changed by -8.60%. Follow the RGNX chart for real-time price dynamics.
What is the stock ticker of REGENXBIO Inc. - Common Stock?
REGENXBIO Inc. - Common Stock trades under the ticker RGNX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is REGENXBIO Inc. - Common Stock stock going up?
RGNX has changed by -14.03% over the last week, +100.47% over the last month, and -5.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was REGENXBIO Inc. - Common Stock net income for the last quarter?
REGENXBIO Inc. - Common Stock reported net income of -90.05 M for the last quarter. The previous quarter showed -67.15 M, which means net income changed by -34.11%.
How many employees does REGENXBIO Inc. - Common Stock have?
As of the latest available data, REGENXBIO Inc. - Common Stock has 371 employees. Workforce size can provide additional context about the company's scale and operations.
What is REGENXBIO Inc. - Common Stock EBITDA?
REGENXBIO Inc. - Common Stock EBITDA is -84.24 M, and its EBITDA margin is -1 317.71%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy REGENXBIO Inc. - Common Stock stock?
You can buy REGENXBIO Inc. - Common Stock (RGNX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in REGENXBIO Inc. - Common Stock stock?
Investing in REGENXBIO Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RGNX chart and related analysis on metatrader.com as part of your research.